Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000230188 | SCV000288955 | benign | Spastic paraplegia | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000382667 | SCV000413616 | likely benign | Spastic paraplegia, autosomal dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000600441 | SCV000714867 | benign | not specified | 2017-08-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics | RCV000600441 | SCV001474660 | benign | not specified | 2020-03-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847960 | SCV002104931 | benign | Hereditary spastic paraplegia | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003311724 | SCV004011078 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | RTN2: BP4, BP7, BS2 |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000600441 | SCV001956905 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000600441 | SCV001974632 | benign | not specified | no assertion criteria provided | clinical testing |